tiprankstipranks
Ocular Therapeutix price target raised to $15 from $14 at H.C. Wainwright
PremiumThe FlyOcular Therapeutix price target raised to $15 from $14 at H.C. Wainwright
2M ago
Ocular Therapeutix Reports Q3 2024 Financial Results
Premium
Company Announcements
Ocular Therapeutix Reports Q3 2024 Financial Results
2M ago
Ocular Therapeutix reports Q3 EPS (22c), consensus (21c)
Premium
The Fly
Ocular Therapeutix reports Q3 EPS (22c), consensus (21c)
2M ago
Ocular Therapeutix management to meet with Piper Sandler
PremiumThe FlyOcular Therapeutix management to meet with Piper Sandler
3M ago
Ocular announces accelerated timelines for SOL-1 registrational trial
Premium
The Fly
Ocular announces accelerated timelines for SOL-1 registrational trial
3M ago
Ocular Therapeutix Expands Stock Incentive Plan for Employees
Premium
Company Announcements
Ocular Therapeutix Expands Stock Incentive Plan for Employees
3M ago
Ocular Therapeutix announces FDA feedback on Phase 3 SOL-R trial
PremiumThe FlyOcular Therapeutix announces FDA feedback on Phase 3 SOL-R trial
5M ago
Ocular Therapeutix sees cash runway into 2028
Premium
The Fly
Ocular Therapeutix sees cash runway into 2028
5M ago
Ocular Therapeutix reports Q2 EPS (26c), consensus (22c)
Premium
The Fly
Ocular Therapeutix reports Q2 EPS (26c), consensus (22c)
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100